Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adherens junction 💬 13 genes, 25 drugs (DrugBank) and 34 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin Mecasermin 💬Adherens junction
| Mecasermin | 096 [4] 96, 168, 265, 299 💬1. Adherens junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adherens junction 💬 13 genes, 25 drugs (DrugBank) and 34 diseases |
IGF1R [1] IGF1R 💬Adherens junction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Adherens junction
| Mecasermin | 096 [4] 96, 168, 265, 299 💬1. Adherens junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adipocytokine signaling pathway 💬 18 genes, 40 drugs (DrugBank) and 108 diseases |
JAK2 [1] JAK2 💬Adipocytokine signaling pathway
|
Baricitinib Baricitinib 💬Adipocytokine signaling pathway
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬3. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Adipocytokine signaling pathway 💬 18 genes, 40 drugs (DrugBank) and 108 diseases |
LEPR [1] LEPR 💬Adipocytokine signaling pathway
|
Metreleptin Metreleptin 💬Adipocytokine signaling pathway
| Metreleptin | 265 [1] 265 💬4. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Adipocytokine signaling pathway 💬 18 genes, 40 drugs (DrugBank) and 108 diseases |
PPARA [1] PPARA 💬Adipocytokine signaling pathway
|
Fenofibrate Fenofibrate 💬Adipocytokine signaling pathway
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬5. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Adipocytokine signaling pathway 💬 18 genes, 40 drugs (DrugBank) and 108 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Adipocytokine signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬6. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Adipocytokine signaling pathway 💬 18 genes, 40 drugs (DrugBank) and 108 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Adipocytokine signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬6. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
JAK2 [1] JAK2 💬AGE-RAGE signaling pathway in diabetic complications
|
Baricitinib Baricitinib 💬AGE-RAGE signaling pathway in diabetic complications
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬8. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
PPARA [1] PPARA 💬Alcoholic liver disease
|
Fenofibrate Fenofibrate 💬Alcoholic liver disease
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬9. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Alcoholic liver disease
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬10. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Alcoholic liver disease
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬10. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Alcoholism 💬 29 genes, 80 drugs (DrugBank) and 63 diseases |
ADORA2A [1] ADORA2A 💬Alcoholism
|
Caffeine Caffeine 💬Alcoholism
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬12. Alcoholism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Alcoholism 💬 29 genes, 80 drugs (DrugBank) and 63 diseases |
ADORA2A [1] ADORA2A 💬Alcoholism
|
Caffeine citrate Caffeine citrate 💬Alcoholism
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬12. Alcoholism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
PDE2A [1] PDE2A 💬Aldosterone synthesis and secretion
|
Caffeine Caffeine 💬Aldosterone synthesis and secretion
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬14. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
PDE2A [1] PDE2A 💬Aldosterone synthesis and secretion
|
Caffeine citrate Caffeine citrate 💬Aldosterone synthesis and secretion
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬14. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Atorvastatin calcium Atorvastatin calcium 💬AMPK signaling pathway
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬16. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Atorvastatin Atorvastatin 💬AMPK signaling pathway
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬16. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Pravastatin sodium Pravastatin sodium 💬AMPK signaling pathway
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬18. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Pravastatin Pravastatin 💬AMPK signaling pathway
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬18. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Simvastatin Simvastatin 💬AMPK signaling pathway
| Simvastatin | 006 [22] 6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬20. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
IGF1R [1] IGF1R 💬AMPK signaling pathway
|
Mecasermin Mecasermin 💬AMPK signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬21. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
IGF1R [1] IGF1R 💬AMPK signaling pathway
|
Mecasermin rinfabate Mecasermin rinfabate 💬AMPK signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬21. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
LEPR [1] LEPR 💬AMPK signaling pathway
|
Metreleptin Metreleptin 💬AMPK signaling pathway
| Metreleptin | 265 [1] 265 💬23. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
PPARG [1] PPARG 💬AMPK signaling pathway
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬AMPK signaling pathway
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬24. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
PPARG [1] PPARG 💬AMPK signaling pathway
|
Pioglitazone Pioglitazone 💬AMPK signaling pathway
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬24. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
PPARG [1] PPARG 💬AMPK signaling pathway
|
Rosiglitazone maleate Rosiglitazone maleate 💬AMPK signaling pathway
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬26. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
PPARG [1] PPARG 💬AMPK signaling pathway
|
Rosiglitazone Rosiglitazone 💬AMPK signaling pathway
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬26. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬AMPK signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬28. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬AMPK signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬28. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
PDE3B [1] PDE3B 💬Apelin signaling pathway
|
Caffeine Caffeine 💬Apelin signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬30. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
PDE3B [1] PDE3B 💬Apelin signaling pathway
|
Caffeine citrate Caffeine citrate 💬Apelin signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬30. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Apelin signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬32. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Apelin signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬32. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Autophagy - animal 💬 14 genes, 21 drugs (DrugBank) and 71 diseases |
IGF1R [1] IGF1R 💬Autophagy - animal
|
Mecasermin Mecasermin 💬Autophagy - animal
| Mecasermin | 096 [4] 96, 168, 265, 299 💬34. Autophagy - animal
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Autophagy - animal 💬 14 genes, 21 drugs (DrugBank) and 71 diseases |
IGF1R [1] IGF1R 💬Autophagy - animal
|
Mecasermin rinfabate Mecasermin rinfabate 💬Autophagy - animal
| Mecasermin | 096 [4] 96, 168, 265, 299 💬34. Autophagy - animal
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Autophagy - animal 💬 14 genes, 21 drugs (DrugBank) and 71 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Autophagy - animal
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬36. Autophagy - animal
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Autophagy - animal 💬 14 genes, 21 drugs (DrugBank) and 71 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Autophagy - animal
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬36. Autophagy - animal
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Atorvastatin calcium Atorvastatin calcium 💬Bile secretion
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬38. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Atorvastatin Atorvastatin 💬Bile secretion
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬38. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Pravastatin sodium Pravastatin sodium 💬Bile secretion
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬40. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Pravastatin Pravastatin 💬Bile secretion
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬40. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Simvastatin Simvastatin 💬Bile secretion
| Simvastatin | 006 [22] 6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬42. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
NR1H4 [1] NR1H4 💬Bile secretion
|
Cholic acid Cholic acid 💬Bile secretion
| Cholic Acid | 020 [4] 20, 234, 265, 310 💬43. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
NR1H4 [1] NR1H4 💬Bile secretion
|
Obeticholic acid Obeticholic acid 💬Bile secretion
| Obeticholic acid | 093 [3] 93, 265, 296 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | Breast cancer 💬 22 genes, 64 drugs (DrugBank) and 84 diseases |
IGF1R [1] IGF1R 💬Breast cancer
|
Mecasermin Mecasermin 💬Breast cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬45. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | Breast cancer 💬 22 genes, 64 drugs (DrugBank) and 84 diseases |
IGF1R [1] IGF1R 💬Breast cancer
|
Mecasermin rinfabate Mecasermin rinfabate 💬Breast cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬45. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | Cadherin signaling 💬 41 genes, 70 drugs (DrugBank) and 81 diseases |
IGF1R [1] IGF1R 💬Cadherin signaling
|
Mecasermin Mecasermin 💬Cadherin signaling
| Mecasermin | 096 [4] 96, 168, 265, 299 💬47. Cadherin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | Cadherin signaling 💬 41 genes, 70 drugs (DrugBank) and 81 diseases |
IGF1R [1] IGF1R 💬Cadherin signaling
|
Mecasermin rinfabate Mecasermin rinfabate 💬Cadherin signaling
| Mecasermin | 096 [4] 96, 168, 265, 299 💬47. Cadherin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADORA2A [2] ADORA2A, PDE1B 💬
|
Caffeine Caffeine 💬Calcium signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬49. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADORA2A [2] ADORA2A, PDE1B 💬
|
Caffeine citrate Caffeine citrate 💬Calcium signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬49. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADORA1 [8] ADORA1, ADORA2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬cAMP signaling pathway
|
Caffeine Caffeine 💬cAMP signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬51. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADORA1 [8] ADORA1, ADORA2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬cAMP signaling pathway
|
Caffeine citrate Caffeine citrate 💬cAMP signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬51. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
GIPR [2] GIPR, GLP1R 💬
|
Tirzepatide Tirzepatide 💬cAMP signaling pathway
| Tirzepatide | 067 [6] 67, 96, 97, 193, 233, 265 💬53. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
PPARA [1] PPARA 💬cAMP signaling pathway
|
Fenofibrate Fenofibrate 💬cAMP signaling pathway
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬54. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADORA1 [5] ADORA1, PDE2A, PDE3A, PDE3B, PDE5A 💬cGMP-PKG signaling pathway
|
Caffeine Caffeine 💬cGMP-PKG signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬55. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADORA1 [5] ADORA1, PDE2A, PDE3A, PDE3B, PDE5A 💬cGMP-PKG signaling pathway
|
Caffeine citrate Caffeine citrate 💬cGMP-PKG signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬55. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
AR [1] AR 💬Chemical carcinogenesis - receptor activation
|
Testosterone Testosterone 💬Chemical carcinogenesis - receptor activation
| Testosterone | 001 [9] 1 , 2 , 3 , 13, 60, 76, 78, 113, 265 💬57. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
JAK2 [1] JAK2 💬Chemical carcinogenesis - receptor activation
|
Baricitinib Baricitinib 💬Chemical carcinogenesis - receptor activation
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬58. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
PPARA [1] PPARA 💬Chemical carcinogenesis - receptor activation
|
Fenofibrate Fenofibrate 💬Chemical carcinogenesis - receptor activation
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬59. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | Chemokine signaling pathway 💬 25 genes, 38 drugs (DrugBank) and 66 diseases |
JAK2 [1] JAK2 💬Chemokine signaling pathway
|
Baricitinib Baricitinib 💬Chemokine signaling pathway
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬60. Chemokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | Cholesterol metabolism 💬 9 genes, 14 drugs (DrugBank) and 9 diseases |
APOC3 [1] APOC3 💬Cholesterol metabolism
|
Volanesorsen Volanesorsen 💬Cholesterol metabolism
| Volanesorsen | 265 [1] 265 💬61. Cholesterol metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Cholesterol metabolism 💬 9 genes, 14 drugs (DrugBank) and 9 diseases |
APOC3 [1] APOC3 💬Cholesterol metabolism
|
Volanesorsen sodium Volanesorsen sodium 💬Cholesterol metabolism
| Volanesorsen | 265 [1] 265 💬61. Cholesterol metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Cholinergic synapse 💬 32 genes, 65 drugs (DrugBank) and 87 diseases |
JAK2 [1] JAK2 💬Cholinergic synapse
|
Baricitinib Baricitinib 💬Cholinergic synapse
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬63. Cholinergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | Circadian entrainment 💬 22 genes, 42 drugs (DrugBank) and 62 diseases |
MTNR1A [2] MTNR1A, MTNR1B 💬
|
Melatonin Melatonin 💬Circadian entrainment
| Melatonin | 002 [18] 2 , 6 , 8 , 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬64. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Circadian rhythm 💬 2 genes, 1 drug (DrugBank) and 31 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Circadian rhythm
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬65. Circadian rhythm
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | Circadian rhythm 💬 2 genes, 1 drug (DrugBank) and 31 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Circadian rhythm
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬65. Circadian rhythm
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
JAK1 [1] JAK1 💬Coronavirus disease
|
Baricitinib Baricitinib 💬Coronavirus disease
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬67. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
GHR [1] GHR 💬Cytokine-cytokine receptor interaction
|
Mecasermin Mecasermin 💬Cytokine-cytokine receptor interaction
| Mecasermin | 096 [4] 96, 168, 265, 299 💬68. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
GHR [1] GHR 💬Cytokine-cytokine receptor interaction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Cytokine-cytokine receptor interaction
| Mecasermin | 096 [4] 96, 168, 265, 299 💬68. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
GHR [1] GHR 💬Cytokine-cytokine receptor interaction
|
Pegvisomant Pegvisomant 💬Cytokine-cytokine receptor interaction
| Pegvisomant | 077 [2] 77, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
LEPR [1] LEPR 💬Cytokine-cytokine receptor interaction
|
Metreleptin Metreleptin 💬Cytokine-cytokine receptor interaction
| Metreleptin | 265 [1] 265 💬71. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
PPARA [1] PPARA 💬Diabetic cardiomyopathy
|
Fenofibrate Fenofibrate 💬Diabetic cardiomyopathy
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬72. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
JAK2 [1] JAK2 💬Efferocytosis
|
Baricitinib Baricitinib 💬Efferocytosis
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬73. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PPARG [1] PPARG 💬Efferocytosis
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Efferocytosis
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬74. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PPARG [1] PPARG 💬Efferocytosis
|
Pioglitazone Pioglitazone 💬Efferocytosis
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬74. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PPARG [1] PPARG 💬Efferocytosis
|
Rosiglitazone maleate Rosiglitazone maleate 💬Efferocytosis
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬76. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PPARG [1] PPARG 💬Efferocytosis
|
Rosiglitazone Rosiglitazone 💬Efferocytosis
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬76. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | Endocytosis 💬 25 genes, 41 drugs (DrugBank) and 54 diseases |
IGF1R [1] IGF1R 💬Endocytosis
|
Mecasermin Mecasermin 💬Endocytosis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬78. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | Endocytosis 💬 25 genes, 41 drugs (DrugBank) and 54 diseases |
IGF1R [1] IGF1R 💬Endocytosis
|
Mecasermin rinfabate Mecasermin rinfabate 💬Endocytosis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬78. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Epstein-Barr virus infection 💬 67 genes, 97 drugs (DrugBank) and 83 diseases |
JAK1 [1] JAK1 💬Epstein-Barr virus infection
|
Baricitinib Baricitinib 💬Epstein-Barr virus infection
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬80. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Fluid shear stress and atherosclerosis
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬81. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Fluid shear stress and atherosclerosis
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬81. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | Focal adhesion 💬 31 genes, 52 drugs (DrugBank) and 54 diseases |
IGF1R [1] IGF1R 💬Focal adhesion
|
Mecasermin Mecasermin 💬Focal adhesion
| Mecasermin | 096 [4] 96, 168, 265, 299 💬83. Focal adhesion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Focal adhesion 💬 31 genes, 52 drugs (DrugBank) and 54 diseases |
IGF1R [1] IGF1R 💬Focal adhesion
|
Mecasermin rinfabate Mecasermin rinfabate 💬Focal adhesion
| Mecasermin | 096 [4] 96, 168, 265, 299 💬83. Focal adhesion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | FoxO signaling pathway 💬 26 genes, 43 drugs (DrugBank) and 62 diseases |
IGF1R [1] IGF1R 💬FoxO signaling pathway
|
Mecasermin Mecasermin 💬FoxO signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬85. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | FoxO signaling pathway 💬 26 genes, 43 drugs (DrugBank) and 62 diseases |
IGF1R [1] IGF1R 💬FoxO signaling pathway
|
Mecasermin rinfabate Mecasermin rinfabate 💬FoxO signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬85. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | FoxO signaling pathway 💬 26 genes, 43 drugs (DrugBank) and 62 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬FoxO signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬87. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | FoxO signaling pathway 💬 26 genes, 43 drugs (DrugBank) and 62 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬FoxO signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬87. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 67 diseases |
IGF1R [1] IGF1R 💬Glioma
|
Mecasermin Mecasermin 💬Glioma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬89. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 67 diseases |
IGF1R [1] IGF1R 💬Glioma
|
Mecasermin rinfabate Mecasermin rinfabate 💬Glioma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬89. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Glucagon signaling pathway 💬 15 genes, 26 drugs (DrugBank) and 85 diseases |
PDE3B [1] PDE3B 💬Glucagon signaling pathway
|
Caffeine Caffeine 💬Glucagon signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬91. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Glucagon signaling pathway 💬 15 genes, 26 drugs (DrugBank) and 85 diseases |
PDE3B [1] PDE3B 💬Glucagon signaling pathway
|
Caffeine citrate Caffeine citrate 💬Glucagon signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬91. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Glucagon signaling pathway 💬 15 genes, 26 drugs (DrugBank) and 85 diseases |
PPARA [1] PPARA 💬Glucagon signaling pathway
|
Fenofibrate Fenofibrate 💬Glucagon signaling pathway
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬93. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Glucagon signaling pathway 💬 15 genes, 26 drugs (DrugBank) and 85 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Glucagon signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬94. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Glucagon signaling pathway 💬 15 genes, 26 drugs (DrugBank) and 85 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Glucagon signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬94. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
GHR [1] GHR 💬Growth hormone synthesis, secretion and action
|
Mecasermin Mecasermin 💬Growth hormone synthesis, secretion and action
| Mecasermin | 096 [4] 96, 168, 265, 299 💬96. Growth hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
GHR [1] GHR 💬Growth hormone synthesis, secretion and action
|
Mecasermin rinfabate Mecasermin rinfabate 💬Growth hormone synthesis, secretion and action
| Mecasermin | 096 [4] 96, 168, 265, 299 💬96. Growth hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
GHR [1] GHR 💬Growth hormone synthesis, secretion and action
|
Pegvisomant Pegvisomant 💬Growth hormone synthesis, secretion and action
| Pegvisomant | 077 [2] 77, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
GHRHR [1] GHRHR 💬Growth hormone synthesis, secretion and action
|
Tesamorelin Tesamorelin 💬Growth hormone synthesis, secretion and action
| Tesamorelin | 265 [1] 265 💬99. Growth hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
GHRHR [1] GHRHR 💬Growth hormone synthesis, secretion and action
|
Tesamorelin acetate Tesamorelin acetate 💬Growth hormone synthesis, secretion and action
| Tesamorelin | 265 [1] 265 💬99. Growth hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 97 diseases |
JAK2 [1] JAK2 💬Growth hormone synthesis, secretion and action
|
Baricitinib Baricitinib 💬Growth hormone synthesis, secretion and action
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬101. Growth hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Hepatitis B 💬 44 genes, 70 drugs (DrugBank) and 92 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Hepatitis B
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬102. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
JAK1 [1] JAK1 💬Hepatitis C
|
Baricitinib Baricitinib 💬Hepatitis C
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬103. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
PPARA [1] PPARA 💬Hepatitis C
|
Fenofibrate Fenofibrate 💬Hepatitis C
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬104. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
IGF1R [1] IGF1R 💬Hepatocellular carcinoma
|
Mecasermin Mecasermin 💬Hepatocellular carcinoma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬105. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
IGF1R [1] IGF1R 💬Hepatocellular carcinoma
|
Mecasermin rinfabate Mecasermin rinfabate 💬Hepatocellular carcinoma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬105. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Herpes simplex virus 1 infection 💬 71 genes, 85 drugs (DrugBank) and 110 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Herpes simplex virus 1 infection
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬107. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
IGF1R [1] IGF1R 💬HIF-1 signaling pathway
|
Mecasermin Mecasermin 💬HIF-1 signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬108. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
IGF1R [1] IGF1R 💬HIF-1 signaling pathway
|
Mecasermin rinfabate Mecasermin rinfabate 💬HIF-1 signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬108. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
GHR [1] GHR 💬Hormone signaling
|
Pegvisomant Pegvisomant 💬Hormone signaling
| Pegvisomant | 077 [2] 77, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
GHR [2] GHR, IGF1R 💬
|
Mecasermin Mecasermin 💬Hormone signaling
| Mecasermin | 096 [4] 96, 168, 265, 299 💬111. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
GHR [2] GHR, IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬Hormone signaling
| Mecasermin | 096 [4] 96, 168, 265, 299 💬111. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
GHRHR [1] GHRHR 💬Hormone signaling
|
Tesamorelin Tesamorelin 💬Hormone signaling
| Tesamorelin | 265 [1] 265 💬113. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
GHRHR [1] GHRHR 💬Hormone signaling
|
Tesamorelin acetate Tesamorelin acetate 💬Hormone signaling
| Tesamorelin | 265 [1] 265 💬113. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
GIPR [2] GIPR, GLP1R 💬
|
Tirzepatide Tirzepatide 💬Hormone signaling
| Tirzepatide | 067 [6] 67, 96, 97, 193, 233, 265 💬115. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
JAK2 [1] JAK2 💬Hormone signaling
|
Baricitinib Baricitinib 💬Hormone signaling
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬116. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
LEPR [1] LEPR 💬Hormone signaling
|
Metreleptin Metreleptin 💬Hormone signaling
| Metreleptin | 265 [1] 265 💬117. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
MC4R [1] MC4R 💬Hormone signaling
|
Setmelanotide Setmelanotide 💬Hormone signaling
| Setmelanotide | 134 [5] 134, 193, 202, 236, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
MC4R [1] MC4R 💬Hormone signaling
|
Setmelanotide acetate Setmelanotide acetate 💬Hormone signaling
| Setmelanotide | 134 [5] 134, 193, 202, 236, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
JAK1 [1] JAK1 💬Human cytomegalovirus infection
|
Baricitinib Baricitinib 💬Human cytomegalovirus infection
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬120. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
JAK1 [1] JAK1 💬Human papillomavirus infection
|
Baricitinib Baricitinib 💬Human papillomavirus infection
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬121. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | Human T-cell leukemia virus 1 infection 💬 61 genes, 80 drugs (DrugBank) and 105 diseases |
JAK1 [1] JAK1 💬Human T-cell leukemia virus 1 infection
|
Baricitinib Baricitinib 💬Human T-cell leukemia virus 1 infection
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬122. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Huntington disease 💬 26 genes, 42 drugs (DrugBank) and 91 diseases |
PPARG [1] PPARG 💬Huntington disease
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Huntington disease
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬123. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | Huntington disease 💬 26 genes, 42 drugs (DrugBank) and 91 diseases |
PPARG [1] PPARG 💬Huntington disease
|
Pioglitazone Pioglitazone 💬Huntington disease
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬123. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | Huntington disease 💬 26 genes, 42 drugs (DrugBank) and 91 diseases |
PPARG [1] PPARG 💬Huntington disease
|
Rosiglitazone maleate Rosiglitazone maleate 💬Huntington disease
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬125. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 126 | Huntington disease 💬 26 genes, 42 drugs (DrugBank) and 91 diseases |
PPARG [1] PPARG 💬Huntington disease
|
Rosiglitazone Rosiglitazone 💬Huntington disease
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬125. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 127 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Hypertrophic cardiomyopathy
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬127. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 128 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Hypertrophic cardiomyopathy
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬127. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 129 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Influenza A
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬129. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 130 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 104 diseases |
PPARA [1] PPARA 💬Insulin resistance
|
Fenofibrate Fenofibrate 💬Insulin resistance
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬130. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 131 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 104 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Insulin resistance
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬131. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 132 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 104 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Insulin resistance
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬131. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 133 | Insulin secretion 💬 16 genes, 51 drugs (DrugBank) and 61 diseases |
GLP1R [1] GLP1R 💬Insulin secretion
|
Tirzepatide Tirzepatide 💬Insulin secretion
| Tirzepatide | 067 [6] 67, 96, 97, 193, 233, 265 💬133. Insulin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 134 | Insulin signaling pathway 💬 13 genes, 28 drugs (DrugBank) and 74 diseases |
PDE3B [1] PDE3B 💬Insulin signaling pathway
|
Caffeine Caffeine 💬Insulin signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬134. Insulin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 135 | Insulin signaling pathway 💬 13 genes, 28 drugs (DrugBank) and 74 diseases |
PDE3B [1] PDE3B 💬Insulin signaling pathway
|
Caffeine citrate Caffeine citrate 💬Insulin signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬134. Insulin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 136 | Insulin signaling pathway 💬 13 genes, 28 drugs (DrugBank) and 74 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Insulin signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬136. Insulin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 137 | Insulin signaling pathway 💬 13 genes, 28 drugs (DrugBank) and 74 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Insulin signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬136. Insulin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 138 | Integrin signaling 💬 28 genes, 48 drugs (DrugBank) and 77 diseases |
IGF1R [1] IGF1R 💬Integrin signaling
|
Mecasermin Mecasermin 💬Integrin signaling
| Mecasermin | 096 [4] 96, 168, 265, 299 💬138. Integrin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 139 | Integrin signaling 💬 28 genes, 48 drugs (DrugBank) and 77 diseases |
IGF1R [1] IGF1R 💬Integrin signaling
|
Mecasermin rinfabate Mecasermin rinfabate 💬Integrin signaling
| Mecasermin | 096 [4] 96, 168, 265, 299 💬138. Integrin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 140 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
GHR [1] GHR 💬JAK-STAT signaling pathway
|
Mecasermin Mecasermin 💬JAK-STAT signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬140. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 141 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
GHR [1] GHR 💬JAK-STAT signaling pathway
|
Mecasermin rinfabate Mecasermin rinfabate 💬JAK-STAT signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬140. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 142 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
GHR [1] GHR 💬JAK-STAT signaling pathway
|
Pegvisomant Pegvisomant 💬JAK-STAT signaling pathway
| Pegvisomant | 077 [2] 77, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 143 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬JAK-STAT signaling pathway
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬143. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 144 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
LEPR [1] LEPR 💬JAK-STAT signaling pathway
|
Metreleptin Metreleptin 💬JAK-STAT signaling pathway
| Metreleptin | 265 [1] 265 💬144. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 145 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Kaposi sarcoma-associated herpesvirus infection
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬145. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 146 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Leishmaniasis
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬146. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 147 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
JAK2 [1] JAK2 💬Lipid and atherosclerosis
|
Baricitinib Baricitinib 💬Lipid and atherosclerosis
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬147. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 148 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
PPARG [1] PPARG 💬Lipid and atherosclerosis
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Lipid and atherosclerosis
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬148. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 149 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
PPARG [1] PPARG 💬Lipid and atherosclerosis
|
Pioglitazone Pioglitazone 💬Lipid and atherosclerosis
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬148. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 150 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
PPARG [1] PPARG 💬Lipid and atherosclerosis
|
Rosiglitazone maleate Rosiglitazone maleate 💬Lipid and atherosclerosis
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬150. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 151 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
PPARG [1] PPARG 💬Lipid and atherosclerosis
|
Rosiglitazone Rosiglitazone 💬Lipid and atherosclerosis
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬150. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 152 | Long-term depression 💬 13 genes, 24 drugs (DrugBank) and 36 diseases |
IGF1R [1] IGF1R 💬Long-term depression
|
Mecasermin Mecasermin 💬Long-term depression
| Mecasermin | 096 [4] 96, 168, 265, 299 💬152. Long-term depression
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 153 | Long-term depression 💬 13 genes, 24 drugs (DrugBank) and 36 diseases |
IGF1R [1] IGF1R 💬Long-term depression
|
Mecasermin rinfabate Mecasermin rinfabate 💬Long-term depression
| Mecasermin | 096 [4] 96, 168, 265, 299 💬152. Long-term depression
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 154 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
IGF1R [1] IGF1R 💬Longevity regulating pathway
|
Mecasermin Mecasermin 💬Longevity regulating pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬154. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 155 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
IGF1R [1] IGF1R 💬Longevity regulating pathway
|
Mecasermin rinfabate Mecasermin rinfabate 💬Longevity regulating pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬154. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 156 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
PPARG [1] PPARG 💬Longevity regulating pathway
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Longevity regulating pathway
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬156. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 157 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
PPARG [1] PPARG 💬Longevity regulating pathway
|
Pioglitazone Pioglitazone 💬Longevity regulating pathway
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬156. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 158 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
PPARG [1] PPARG 💬Longevity regulating pathway
|
Rosiglitazone maleate Rosiglitazone maleate 💬Longevity regulating pathway
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬158. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 159 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
PPARG [1] PPARG 💬Longevity regulating pathway
|
Rosiglitazone Rosiglitazone 💬Longevity regulating pathway
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬158. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 160 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Longevity regulating pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬160. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 161 | Longevity regulating pathway 💬 11 genes, 23 drugs (DrugBank) and 73 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Longevity regulating pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬160. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 162 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 70 diseases |
IGF1R [1] IGF1R 💬Longevity regulating pathway - multiple species
|
Mecasermin Mecasermin 💬Longevity regulating pathway - multiple species
| Mecasermin | 096 [4] 96, 168, 265, 299 💬162. Longevity regulating pathway - multiple species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 163 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 70 diseases |
IGF1R [1] IGF1R 💬Longevity regulating pathway - multiple species
|
Mecasermin rinfabate Mecasermin rinfabate 💬Longevity regulating pathway - multiple species
| Mecasermin | 096 [4] 96, 168, 265, 299 💬162. Longevity regulating pathway - multiple species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 164 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 70 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Longevity regulating pathway - multiple species
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬164. Longevity regulating pathway - multiple species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 165 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 70 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Longevity regulating pathway - multiple species
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬164. Longevity regulating pathway - multiple species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 166 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
IGF1R [1] IGF1R 💬MAPK signaling pathway
|
Mecasermin Mecasermin 💬MAPK signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬166. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 167 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
IGF1R [1] IGF1R 💬MAPK signaling pathway
|
Mecasermin rinfabate Mecasermin rinfabate 💬MAPK signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬166. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 168 | Measles 💬 42 genes, 72 drugs (DrugBank) and 70 diseases |
JAK1 [1] JAK1 💬Measles
|
Baricitinib Baricitinib 💬Measles
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬168. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 169 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 45 diseases |
IGF1R [1] IGF1R 💬Melanoma
|
Mecasermin Mecasermin 💬Melanoma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬169. Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 170 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 45 diseases |
IGF1R [1] IGF1R 💬Melanoma
|
Mecasermin rinfabate Mecasermin rinfabate 💬Melanoma
| Mecasermin | 096 [4] 96, 168, 265, 299 💬169. Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 171 | Morphine addiction 💬 43 genes, 70 drugs (DrugBank) and 80 diseases |
ADORA1 [9] ADORA1, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬Morphine addiction
|
Caffeine Caffeine 💬Morphine addiction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬171. Morphine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 172 | Morphine addiction 💬 43 genes, 70 drugs (DrugBank) and 80 diseases |
ADORA1 [9] ADORA1, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬Morphine addiction
|
Caffeine citrate Caffeine citrate 💬Morphine addiction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬171. Morphine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 173 | mTOR signaling pathway 💬 15 genes, 33 drugs (DrugBank) and 99 diseases |
IGF1R [1] IGF1R 💬mTOR signaling pathway
|
Mecasermin Mecasermin 💬mTOR signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬173. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 174 | mTOR signaling pathway 💬 15 genes, 33 drugs (DrugBank) and 99 diseases |
IGF1R [1] IGF1R 💬mTOR signaling pathway
|
Mecasermin rinfabate Mecasermin rinfabate 💬mTOR signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬173. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 175 | mTOR signaling pathway 💬 15 genes, 33 drugs (DrugBank) and 99 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬mTOR signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬175. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 176 | mTOR signaling pathway 💬 15 genes, 33 drugs (DrugBank) and 99 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬mTOR signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬175. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 177 | Necroptosis 💬 34 genes, 60 drugs (DrugBank) and 82 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Necroptosis
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬177. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 178 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADORA1 [2] ADORA1, ADORA2A 💬
|
Caffeine Caffeine 💬Neuroactive ligand signaling
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬178. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 179 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADORA1 [2] ADORA1, ADORA2A 💬
|
Caffeine citrate Caffeine citrate 💬Neuroactive ligand signaling
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬178. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 180 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
MC4R [1] MC4R 💬Neuroactive ligand signaling
|
Setmelanotide Setmelanotide 💬Neuroactive ligand signaling
| Setmelanotide | 134 [5] 134, 193, 202, 236, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 181 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
MC4R [1] MC4R 💬Neuroactive ligand signaling
|
Setmelanotide acetate Setmelanotide acetate 💬Neuroactive ligand signaling
| Setmelanotide | 134 [5] 134, 193, 202, 236, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 182 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADORA1 [2] ADORA1, ADORA2A 💬
|
Caffeine Caffeine 💬Neuroactive ligand-receptor interaction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬182. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 183 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADORA1 [2] ADORA1, ADORA2A 💬
|
Caffeine citrate Caffeine citrate 💬Neuroactive ligand-receptor interaction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬182. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 184 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
GHR [1] GHR 💬Neuroactive ligand-receptor interaction
|
Mecasermin Mecasermin 💬Neuroactive ligand-receptor interaction
| Mecasermin | 096 [4] 96, 168, 265, 299 💬184. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 185 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
GHR [1] GHR 💬Neuroactive ligand-receptor interaction
|
Mecasermin rinfabate Mecasermin rinfabate 💬Neuroactive ligand-receptor interaction
| Mecasermin | 096 [4] 96, 168, 265, 299 💬184. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 186 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
GHR [1] GHR 💬Neuroactive ligand-receptor interaction
|
Pegvisomant Pegvisomant 💬Neuroactive ligand-receptor interaction
| Pegvisomant | 077 [2] 77, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 187 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
GHRHR [1] GHRHR 💬Neuroactive ligand-receptor interaction
|
Tesamorelin Tesamorelin 💬Neuroactive ligand-receptor interaction
| Tesamorelin | 265 [1] 265 💬187. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 188 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
GHRHR [1] GHRHR 💬Neuroactive ligand-receptor interaction
|
Tesamorelin acetate Tesamorelin acetate 💬Neuroactive ligand-receptor interaction
| Tesamorelin | 265 [1] 265 💬187. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 189 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
GIPR [2] GIPR, GLP1R 💬
|
Tirzepatide Tirzepatide 💬Neuroactive ligand-receptor interaction
| Tirzepatide | 067 [6] 67, 96, 97, 193, 233, 265 💬189. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 190 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
LEPR [1] LEPR 💬Neuroactive ligand-receptor interaction
|
Metreleptin Metreleptin 💬Neuroactive ligand-receptor interaction
| Metreleptin | 265 [1] 265 💬190. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 191 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
MC4R [1] MC4R 💬Neuroactive ligand-receptor interaction
|
Setmelanotide Setmelanotide 💬Neuroactive ligand-receptor interaction
| Setmelanotide | 134 [5] 134, 193, 202, 236, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 192 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
MC4R [1] MC4R 💬Neuroactive ligand-receptor interaction
|
Setmelanotide acetate Setmelanotide acetate 💬Neuroactive ligand-receptor interaction
| Setmelanotide | 134 [5] 134, 193, 202, 236, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 193 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
MTNR1A [2] MTNR1A, MTNR1B 💬
|
Melatonin Melatonin 💬Neuroactive ligand-receptor interaction
| Melatonin | 002 [18] 2 , 6 , 8 , 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬193. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 194 | NOD-like receptor signaling pathway 💬 33 genes, 57 drugs (DrugBank) and 79 diseases |
JAK1 [1] JAK1 💬NOD-like receptor signaling pathway
|
Baricitinib Baricitinib 💬NOD-like receptor signaling pathway
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬194. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 195 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
LEPR [1] LEPR 💬Non-alcoholic fatty liver disease
|
Metreleptin Metreleptin 💬Non-alcoholic fatty liver disease
| Metreleptin | 265 [1] 265 💬195. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 196 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PPARA [1] PPARA 💬Non-alcoholic fatty liver disease
|
Fenofibrate Fenofibrate 💬Non-alcoholic fatty liver disease
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬196. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 197 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PPARG [1] PPARG 💬Non-alcoholic fatty liver disease
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Non-alcoholic fatty liver disease
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬197. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 198 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PPARG [1] PPARG 💬Non-alcoholic fatty liver disease
|
Pioglitazone Pioglitazone 💬Non-alcoholic fatty liver disease
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬197. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 199 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PPARG [1] PPARG 💬Non-alcoholic fatty liver disease
|
Rosiglitazone maleate Rosiglitazone maleate 💬Non-alcoholic fatty liver disease
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬199. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 200 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PPARG [1] PPARG 💬Non-alcoholic fatty liver disease
|
Rosiglitazone Rosiglitazone 💬Non-alcoholic fatty liver disease
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬199. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 201 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Non-alcoholic fatty liver disease
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬201. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 202 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Non-alcoholic fatty liver disease
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬201. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 203 | Olfactory transduction 💬 6 genes, 7 drugs (DrugBank) and 14 diseases |
PDE1B [2] PDE1B, PDE2A 💬
|
Caffeine Caffeine 💬Olfactory transduction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬203. Olfactory transduction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 204 | Olfactory transduction 💬 6 genes, 7 drugs (DrugBank) and 14 diseases |
PDE1B [2] PDE1B, PDE2A 💬
|
Caffeine citrate Caffeine citrate 💬Olfactory transduction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬203. Olfactory transduction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 205 | Oocyte meiosis 💬 14 genes, 39 drugs (DrugBank) and 73 diseases |
AR [1] AR 💬Oocyte meiosis
|
Testosterone Testosterone 💬Oocyte meiosis
| Testosterone | 001 [9] 1 , 2 , 3 , 13, 60, 76, 78, 113, 265 💬205. Oocyte meiosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 206 | Oocyte meiosis 💬 14 genes, 39 drugs (DrugBank) and 73 diseases |
IGF1R [1] IGF1R 💬Oocyte meiosis
|
Mecasermin Mecasermin 💬Oocyte meiosis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬206. Oocyte meiosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 207 | Oocyte meiosis 💬 14 genes, 39 drugs (DrugBank) and 73 diseases |
IGF1R [1] IGF1R 💬Oocyte meiosis
|
Mecasermin rinfabate Mecasermin rinfabate 💬Oocyte meiosis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬206. Oocyte meiosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 208 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
JAK1 [1] JAK1 💬Osteoclast differentiation
|
Baricitinib Baricitinib 💬Osteoclast differentiation
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬208. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 209 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
PPARG [1] PPARG 💬Osteoclast differentiation
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Osteoclast differentiation
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬209. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 210 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
PPARG [1] PPARG 💬Osteoclast differentiation
|
Pioglitazone Pioglitazone 💬Osteoclast differentiation
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬209. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 211 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
PPARG [1] PPARG 💬Osteoclast differentiation
|
Rosiglitazone maleate Rosiglitazone maleate 💬Osteoclast differentiation
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬211. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 212 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
PPARG [1] PPARG 💬Osteoclast differentiation
|
Rosiglitazone Rosiglitazone 💬Osteoclast differentiation
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬211. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 213 | Ovarian steroidogenesis 💬 7 genes, 40 drugs (DrugBank) and 53 diseases |
IGF1R [1] IGF1R 💬Ovarian steroidogenesis
|
Mecasermin Mecasermin 💬Ovarian steroidogenesis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬213. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 214 | Ovarian steroidogenesis 💬 7 genes, 40 drugs (DrugBank) and 53 diseases |
IGF1R [1] IGF1R 💬Ovarian steroidogenesis
|
Mecasermin rinfabate Mecasermin rinfabate 💬Ovarian steroidogenesis
| Mecasermin | 096 [4] 96, 168, 265, 299 💬213. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 215 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Oxytocin signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬215. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 216 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Oxytocin signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬215. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 217 | Pancreatic cancer 💬 20 genes, 43 drugs (DrugBank) and 86 diseases |
JAK1 [1] JAK1 💬Pancreatic cancer
|
Baricitinib Baricitinib 💬Pancreatic cancer
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬217. Pancreatic cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 218 | Parathyroid hormone synthesis, secretion and action 💬 24 genes, 63 drugs (DrugBank) and 70 diseases |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬
|
Caffeine Caffeine 💬Parathyroid hormone synthesis, secretion and action
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬218. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 219 | Parathyroid hormone synthesis, secretion and action 💬 24 genes, 63 drugs (DrugBank) and 70 diseases |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬
|
Caffeine citrate Caffeine citrate 💬Parathyroid hormone synthesis, secretion and action
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬218. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 220 | Parkinson disease 💬 24 genes, 73 drugs (DrugBank) and 71 diseases |
ADORA2A [1] ADORA2A 💬Parkinson disease
|
Caffeine Caffeine 💬Parkinson disease
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬220. Parkinson disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 221 | Parkinson disease 💬 24 genes, 73 drugs (DrugBank) and 71 diseases |
ADORA2A [1] ADORA2A 💬Parkinson disease
|
Caffeine citrate Caffeine citrate 💬Parkinson disease
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬220. Parkinson disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 222 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
AR [1] AR 💬Pathways in cancer
|
Testosterone Testosterone 💬Pathways in cancer
| Testosterone | 001 [9] 1 , 2 , 3 , 13, 60, 76, 78, 113, 265 💬222. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 223 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
IGF1R [1] IGF1R 💬Pathways in cancer
|
Mecasermin Mecasermin 💬Pathways in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬223. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 224 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
IGF1R [1] IGF1R 💬Pathways in cancer
|
Mecasermin rinfabate Mecasermin rinfabate 💬Pathways in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬223. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 225 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Pathways in cancer
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬225. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 226 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PPARG [1] PPARG 💬Pathways in cancer
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Pathways in cancer
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬226. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 227 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PPARG [1] PPARG 💬Pathways in cancer
|
Pioglitazone Pioglitazone 💬Pathways in cancer
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬226. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 228 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PPARG [1] PPARG 💬Pathways in cancer
|
Rosiglitazone maleate Rosiglitazone maleate 💬Pathways in cancer
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬228. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 229 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PPARG [1] PPARG 💬Pathways in cancer
|
Rosiglitazone Rosiglitazone 💬Pathways in cancer
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬228. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 230 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 70 drugs (DrugBank) and 104 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬230. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 231 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
GHR [1] GHR 💬PI3K-Akt signaling pathway
|
Pegvisomant Pegvisomant 💬PI3K-Akt signaling pathway
| Pegvisomant | 077 [2] 77, 265 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 232 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
GHR [2] GHR, IGF1R 💬
|
Mecasermin Mecasermin 💬PI3K-Akt signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬232. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 233 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
GHR [2] GHR, IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬PI3K-Akt signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬232. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 234 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬PI3K-Akt signaling pathway
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬234. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 235 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬PI3K-Akt signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬235. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 236 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬PI3K-Akt signaling pathway
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬235. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 237 | PPAR signaling pathway 💬 12 genes, 19 drugs (DrugBank) and 38 diseases |
APOC3 [1] APOC3 💬PPAR signaling pathway
|
Volanesorsen Volanesorsen 💬PPAR signaling pathway
| Volanesorsen | 265 [1] 265 💬237. PPAR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 238 | PPAR signaling pathway 💬 12 genes, 19 drugs (DrugBank) and 38 diseases |
APOC3 [1] APOC3 💬PPAR signaling pathway
|
Volanesorsen sodium Volanesorsen sodium 💬PPAR signaling pathway
| Volanesorsen | 265 [1] 265 💬237. PPAR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 239 | PPAR signaling pathway 💬 12 genes, 19 drugs (DrugBank) and 38 diseases |
PPARA [1] PPARA 💬PPAR signaling pathway
|
Fenofibrate Fenofibrate 💬PPAR signaling pathway
| Fenofibrate | 008 [6] 8 , 79, 93, 94, 97, 265 💬239. PPAR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 240 | PPAR signaling pathway 💬 12 genes, 19 drugs (DrugBank) and 38 diseases |
PPARG [1] PPARG 💬PPAR signaling pathway
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬PPAR signaling pathway
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬240. PPAR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 241 | PPAR signaling pathway 💬 12 genes, 19 drugs (DrugBank) and 38 diseases |
PPARG [1] PPARG 💬PPAR signaling pathway
|
Pioglitazone Pioglitazone 💬PPAR signaling pathway
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬240. PPAR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 242 | PPAR signaling pathway 💬 12 genes, 19 drugs (DrugBank) and 38 diseases |
PPARG [1] PPARG 💬PPAR signaling pathway
|
Rosiglitazone maleate Rosiglitazone maleate 💬PPAR signaling pathway
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬242. PPAR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 243 | PPAR signaling pathway 💬 12 genes, 19 drugs (DrugBank) and 38 diseases |
PPARG [1] PPARG 💬PPAR signaling pathway
|
Rosiglitazone Rosiglitazone 💬PPAR signaling pathway
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬242. PPAR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 244 | Progesterone-mediated oocyte maturation 💬 14 genes, 39 drugs (DrugBank) and 47 diseases |
IGF1R [1] IGF1R 💬Progesterone-mediated oocyte maturation
|
Mecasermin Mecasermin 💬Progesterone-mediated oocyte maturation
| Mecasermin | 096 [4] 96, 168, 265, 299 💬244. Progesterone-mediated oocyte maturation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 245 | Progesterone-mediated oocyte maturation 💬 14 genes, 39 drugs (DrugBank) and 47 diseases |
IGF1R [1] IGF1R 💬Progesterone-mediated oocyte maturation
|
Mecasermin rinfabate Mecasermin rinfabate 💬Progesterone-mediated oocyte maturation
| Mecasermin | 096 [4] 96, 168, 265, 299 💬244. Progesterone-mediated oocyte maturation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 246 | Progesterone-mediated oocyte maturation 💬 14 genes, 39 drugs (DrugBank) and 47 diseases |
PDE3B [1] PDE3B 💬Progesterone-mediated oocyte maturation
|
Caffeine Caffeine 💬Progesterone-mediated oocyte maturation
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬246. Progesterone-mediated oocyte maturation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 247 | Progesterone-mediated oocyte maturation 💬 14 genes, 39 drugs (DrugBank) and 47 diseases |
PDE3B [1] PDE3B 💬Progesterone-mediated oocyte maturation
|
Caffeine citrate Caffeine citrate 💬Progesterone-mediated oocyte maturation
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬246. Progesterone-mediated oocyte maturation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 248 | Prolactin signaling pathway 💬 20 genes, 44 drugs (DrugBank) and 74 diseases |
JAK2 [1] JAK2 💬Prolactin signaling pathway
|
Baricitinib Baricitinib 💬Prolactin signaling pathway
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬248. Prolactin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 249 | Prostate cancer 💬 24 genes, 58 drugs (DrugBank) and 92 diseases |
AR [1] AR 💬Prostate cancer
|
Testosterone Testosterone 💬Prostate cancer
| Testosterone | 001 [9] 1 , 2 , 3 , 13, 60, 76, 78, 113, 265 💬249. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 250 | Prostate cancer 💬 24 genes, 58 drugs (DrugBank) and 92 diseases |
IGF1R [1] IGF1R 💬Prostate cancer
|
Mecasermin Mecasermin 💬Prostate cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬250. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 251 | Prostate cancer 💬 24 genes, 58 drugs (DrugBank) and 92 diseases |
IGF1R [1] IGF1R 💬Prostate cancer
|
Mecasermin rinfabate Mecasermin rinfabate 💬Prostate cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬250. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 252 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
IGF1R [1] IGF1R 💬Proteoglycans in cancer
|
Mecasermin Mecasermin 💬Proteoglycans in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬252. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 253 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
IGF1R [1] IGF1R 💬Proteoglycans in cancer
|
Mecasermin rinfabate Mecasermin rinfabate 💬Proteoglycans in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬252. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 254 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE1B [9] PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬Purine metabolism
|
Caffeine Caffeine 💬Purine metabolism
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬254. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 255 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE1B [9] PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬Purine metabolism
|
Caffeine citrate Caffeine citrate 💬Purine metabolism
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬254. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 256 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
ADORA2A [1] ADORA2A 💬Rap1 signaling pathway
|
Caffeine Caffeine 💬Rap1 signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬256. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 257 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
ADORA2A [1] ADORA2A 💬Rap1 signaling pathway
|
Caffeine citrate Caffeine citrate 💬Rap1 signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬256. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 258 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
IGF1R [1] IGF1R 💬Rap1 signaling pathway
|
Mecasermin Mecasermin 💬Rap1 signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬258. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 259 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
IGF1R [1] IGF1R 💬Rap1 signaling pathway
|
Mecasermin rinfabate Mecasermin rinfabate 💬Rap1 signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬258. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 260 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
IGF1R [1] IGF1R 💬Ras signaling pathway
|
Mecasermin Mecasermin 💬Ras signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬260. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 261 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
IGF1R [1] IGF1R 💬Ras signaling pathway
|
Mecasermin rinfabate Mecasermin rinfabate 💬Ras signaling pathway
| Mecasermin | 096 [4] 96, 168, 265, 299 💬260. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 262 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADORA1 [2] ADORA1, PDE3B 💬
|
Caffeine Caffeine 💬Regulation of lipolysis in adipocytes
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬262. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 263 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADORA1 [2] ADORA1, PDE3B 💬
|
Caffeine citrate Caffeine citrate 💬Regulation of lipolysis in adipocytes
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬262. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 264 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADORA1 [4] ADORA1, PDE1B, PDE3A, PDE3B 💬
|
Caffeine Caffeine 💬Renin secretion
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬264. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 265 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADORA1 [4] ADORA1, PDE1B, PDE3A, PDE3B 💬
|
Caffeine citrate Caffeine citrate 💬Renin secretion
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬264. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 266 | Signaling pathways regulating pluripotency of stem cells 💬 21 genes, 39 drugs (DrugBank) and 64 diseases |
IGF1R [1] IGF1R 💬Signaling pathways regulating pluripotency of stem cells
|
Mecasermin Mecasermin 💬Signaling pathways regulating pluripotency of stem cells
| Mecasermin | 096 [4] 96, 168, 265, 299 💬266. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 267 | Signaling pathways regulating pluripotency of stem cells 💬 21 genes, 39 drugs (DrugBank) and 64 diseases |
IGF1R [1] IGF1R 💬Signaling pathways regulating pluripotency of stem cells
|
Mecasermin rinfabate Mecasermin rinfabate 💬Signaling pathways regulating pluripotency of stem cells
| Mecasermin | 096 [4] 96, 168, 265, 299 💬266. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 268 | Signaling pathways regulating pluripotency of stem cells 💬 21 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Signaling pathways regulating pluripotency of stem cells
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬268. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 269 | Sphingolipid signaling pathway 💬 32 genes, 56 drugs (DrugBank) and 84 diseases |
ADORA1 [1] ADORA1 💬Sphingolipid signaling pathway
|
Caffeine Caffeine 💬Sphingolipid signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬269. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 270 | Sphingolipid signaling pathway 💬 32 genes, 56 drugs (DrugBank) and 84 diseases |
ADORA1 [1] ADORA1 💬Sphingolipid signaling pathway
|
Caffeine citrate Caffeine citrate 💬Sphingolipid signaling pathway
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬269. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 271 | Taste transduction 💬 29 genes, 93 drugs (DrugBank) and 78 diseases |
PDE1B [1] PDE1B 💬Taste transduction
|
Caffeine Caffeine 💬Taste transduction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬271. Taste transduction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 272 | Taste transduction 💬 29 genes, 93 drugs (DrugBank) and 78 diseases |
PDE1B [1] PDE1B 💬Taste transduction
|
Caffeine citrate Caffeine citrate 💬Taste transduction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬271. Taste transduction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 273 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Atorvastatin calcium Atorvastatin calcium 💬Terpenoid backbone biosynthesis
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬273. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 274 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Atorvastatin Atorvastatin 💬Terpenoid backbone biosynthesis
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬273. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 275 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Pravastatin sodium Pravastatin sodium 💬Terpenoid backbone biosynthesis
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬275. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 276 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Pravastatin Pravastatin 💬Terpenoid backbone biosynthesis
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬275. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 277 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Simvastatin Simvastatin 💬Terpenoid backbone biosynthesis
| Simvastatin | 006 [22] 6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬277. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 278 | Th1 and Th2 cell differentiation 💬 45 genes, 57 drugs (DrugBank) and 83 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Th1 and Th2 cell differentiation
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬278. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 279 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Th17 cell differentiation
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬279. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 280 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
PPARG [1] PPARG 💬Thermogenesis
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Thermogenesis
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬280. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 281 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
PPARG [1] PPARG 💬Thermogenesis
|
Pioglitazone Pioglitazone 💬Thermogenesis
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬280. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 282 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
PPARG [1] PPARG 💬Thermogenesis
|
Rosiglitazone maleate Rosiglitazone maleate 💬Thermogenesis
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬282. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 283 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
PPARG [1] PPARG 💬Thermogenesis
|
Rosiglitazone Rosiglitazone 💬Thermogenesis
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬282. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 284 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Thermogenesis
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬284. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 285 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 89 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Thermogenesis
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬284. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 286 | Thyroid cancer 💬 8 genes, 18 drugs (DrugBank) and 35 diseases |
PPARG [1] PPARG 💬Thyroid cancer
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Thyroid cancer
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬286. Thyroid cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 287 | Thyroid cancer 💬 8 genes, 18 drugs (DrugBank) and 35 diseases |
PPARG [1] PPARG 💬Thyroid cancer
|
Pioglitazone Pioglitazone 💬Thyroid cancer
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬286. Thyroid cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 288 | Thyroid cancer 💬 8 genes, 18 drugs (DrugBank) and 35 diseases |
PPARG [1] PPARG 💬Thyroid cancer
|
Rosiglitazone maleate Rosiglitazone maleate 💬Thyroid cancer
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬288. Thyroid cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 289 | Thyroid cancer 💬 8 genes, 18 drugs (DrugBank) and 35 diseases |
PPARG [1] PPARG 💬Thyroid cancer
|
Rosiglitazone Rosiglitazone 💬Thyroid cancer
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬288. Thyroid cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 290 | Tight junction 💬 13 genes, 38 drugs (DrugBank) and 54 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin hydrochloride Metformin hydrochloride 💬Tight junction
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬290. Tight junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 291 | Tight junction 💬 13 genes, 38 drugs (DrugBank) and 54 diseases |
PRKAA1 [2] PRKAA1, PRKAA2 💬
|
Metformin Metformin 💬Tight junction
| Metformin | 002 [31] 2 , 6 , 8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬290. Tight junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 292 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
JAK1 [1] JAK1 💬Toll-like receptor signaling pathway
|
Baricitinib Baricitinib 💬Toll-like receptor signaling pathway
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬292. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 293 | Toxoplasmosis 💬 41 genes, 53 drugs (DrugBank) and 78 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Toxoplasmosis
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬293. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 294 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
IGF1R [1] IGF1R 💬Transcriptional misregulation in cancer
|
Mecasermin Mecasermin 💬Transcriptional misregulation in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬294. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 295 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
IGF1R [1] IGF1R 💬Transcriptional misregulation in cancer
|
Mecasermin rinfabate Mecasermin rinfabate 💬Transcriptional misregulation in cancer
| Mecasermin | 096 [4] 96, 168, 265, 299 💬294. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 296 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
PPARG [1] PPARG 💬Transcriptional misregulation in cancer
|
Pioglitazone hydrochloride Pioglitazone hydrochloride 💬Transcriptional misregulation in cancer
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬296. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 297 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
PPARG [1] PPARG 💬Transcriptional misregulation in cancer
|
Pioglitazone Pioglitazone 💬Transcriptional misregulation in cancer
| Pioglitazone | 002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬296. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 298 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
PPARG [1] PPARG 💬Transcriptional misregulation in cancer
|
Rosiglitazone maleate Rosiglitazone maleate 💬Transcriptional misregulation in cancer
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬298. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 299 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
PPARG [1] PPARG 💬Transcriptional misregulation in cancer
|
Rosiglitazone Rosiglitazone 💬Transcriptional misregulation in cancer
| Rosiglitazone | 046 [7] 46, 57, 75, 77, 97, 222, 265 💬298. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 300 | Tuberculosis 💬 67 genes, 80 drugs (DrugBank) and 104 diseases |
JAK1 [2] JAK1, JAK2 💬
|
Baricitinib Baricitinib 💬Tuberculosis
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬300. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 301 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
ADORA2A [1] ADORA2A 💬Vascular smooth muscle contraction
|
Caffeine Caffeine 💬Vascular smooth muscle contraction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬301. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 302 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
ADORA2A [1] ADORA2A 💬Vascular smooth muscle contraction
|
Caffeine citrate Caffeine citrate 💬Vascular smooth muscle contraction
| Caffeine | 002 [8] 2 , 6 , 13, 21, 46, 96, 97, 265 💬301. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 303 | Viral carcinogenesis 💬 32 genes, 34 drugs (DrugBank) and 60 diseases |
JAK1 [1] JAK1 💬Viral carcinogenesis
|
Baricitinib Baricitinib 💬Viral carcinogenesis
| Baricitinib | 002 [24] 2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬303. Viral carcinogenesis
|
Adherens junction
13 genes, 25 drugs (DrugBank) and 34 diseases
Adipocytokine signaling pathway
18 genes, 40 drugs (DrugBank) and 108 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Alcoholic liver disease
43 genes, 56 drugs (DrugBank) and 98 diseases
Alcoholism
29 genes, 80 drugs (DrugBank) and 63 diseases
Aldosterone synthesis and secretion
20 genes, 43 drugs (DrugBank) and 63 diseases
AMPK signaling pathway
16 genes, 58 drugs (DrugBank) and 100 diseases
Apelin signaling pathway
18 genes, 37 drugs (DrugBank) and 81 diseases
Autophagy - animal
14 genes, 21 drugs (DrugBank) and 71 diseases
Bile secretion
13 genes, 36 drugs (DrugBank) and 66 diseases
Breast cancer
22 genes, 64 drugs (DrugBank) and 84 diseases
Cadherin signaling
41 genes, 70 drugs (DrugBank) and 81 diseases
Calcium signaling pathway
82 genes, 215 drugs (DrugBank) and 140 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Chemokine signaling pathway
25 genes, 38 drugs (DrugBank) and 66 diseases
Cholesterol metabolism
9 genes, 14 drugs (DrugBank) and 9 diseases
Cholinergic synapse
32 genes, 65 drugs (DrugBank) and 87 diseases
Circadian entrainment
22 genes, 42 drugs (DrugBank) and 62 diseases
Circadian rhythm
2 genes, 1 drug (DrugBank) and 31 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Cytokine-cytokine receptor interaction
90 genes, 141 drugs (DrugBank) and 104 diseases
Diabetic cardiomyopathy
25 genes, 48 drugs (DrugBank) and 80 diseases
Efferocytosis
30 genes, 78 drugs (DrugBank) and 97 diseases
Endocytosis
25 genes, 41 drugs (DrugBank) and 54 diseases
Epstein-Barr virus infection
67 genes, 97 drugs (DrugBank) and 83 diseases
Fluid shear stress and atherosclerosis
33 genes, 60 drugs (DrugBank) and 100 diseases
Focal adhesion
31 genes, 52 drugs (DrugBank) and 54 diseases
FoxO signaling pathway
26 genes, 43 drugs (DrugBank) and 62 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 67 diseases
Glucagon signaling pathway
15 genes, 26 drugs (DrugBank) and 85 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 97 diseases
Hepatitis B
44 genes, 70 drugs (DrugBank) and 92 diseases
Hepatitis C
37 genes, 75 drugs (DrugBank) and 92 diseases
Hepatocellular carcinoma
22 genes, 33 drugs (DrugBank) and 70 diseases
Herpes simplex virus 1 infection
71 genes, 85 drugs (DrugBank) and 110 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human papillomavirus infection
52 genes, 114 drugs (DrugBank) and 121 diseases
Human T-cell leukemia virus 1 infection
61 genes, 80 drugs (DrugBank) and 105 diseases
Huntington disease
26 genes, 42 drugs (DrugBank) and 91 diseases
Hypertrophic cardiomyopathy
26 genes, 57 drugs (DrugBank) and 97 diseases
Influenza A
67 genes, 84 drugs (DrugBank) and 101 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 104 diseases
Insulin secretion
16 genes, 51 drugs (DrugBank) and 61 diseases
Insulin signaling pathway
13 genes, 28 drugs (DrugBank) and 74 diseases
Integrin signaling
28 genes, 48 drugs (DrugBank) and 77 diseases
JAK-STAT signaling pathway
60 genes, 117 drugs (DrugBank) and 116 diseases
Kaposi sarcoma-associated herpesvirus infection
61 genes, 102 drugs (DrugBank) and 124 diseases
Leishmaniasis
40 genes, 76 drugs (DrugBank) and 105 diseases
Lipid and atherosclerosis
52 genes, 73 drugs (DrugBank) and 107 diseases
Long-term depression
13 genes, 24 drugs (DrugBank) and 36 diseases
Longevity regulating pathway
11 genes, 23 drugs (DrugBank) and 73 diseases
Longevity regulating pathway - multiple species
11 genes, 18 drugs (DrugBank) and 70 diseases
MAPK signaling pathway
70 genes, 101 drugs (DrugBank) and 117 diseases
Measles
42 genes, 72 drugs (DrugBank) and 70 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 45 diseases
Morphine addiction
43 genes, 70 drugs (DrugBank) and 80 diseases
mTOR signaling pathway
15 genes, 33 drugs (DrugBank) and 99 diseases
Necroptosis
34 genes, 60 drugs (DrugBank) and 82 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
NOD-like receptor signaling pathway
33 genes, 57 drugs (DrugBank) and 79 diseases
Non-alcoholic fatty liver disease
24 genes, 54 drugs (DrugBank) and 100 diseases
Olfactory transduction
6 genes, 7 drugs (DrugBank) and 14 diseases
Oocyte meiosis
14 genes, 39 drugs (DrugBank) and 73 diseases
Osteoclast differentiation
40 genes, 93 drugs (DrugBank) and 109 diseases
Ovarian steroidogenesis
7 genes, 40 drugs (DrugBank) and 53 diseases
Oxytocin signaling pathway
34 genes, 85 drugs (DrugBank) and 112 diseases
Pancreatic cancer
20 genes, 43 drugs (DrugBank) and 86 diseases
Parathyroid hormone synthesis, secretion and action
24 genes, 63 drugs (DrugBank) and 70 diseases
Parkinson disease
24 genes, 73 drugs (DrugBank) and 71 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
34 genes, 70 drugs (DrugBank) and 104 diseases
PI3K-Akt signaling pathway
86 genes, 147 drugs (DrugBank) and 129 diseases
PPAR signaling pathway
12 genes, 19 drugs (DrugBank) and 38 diseases
Progesterone-mediated oocyte maturation
14 genes, 39 drugs (DrugBank) and 47 diseases
Prolactin signaling pathway
20 genes, 44 drugs (DrugBank) and 74 diseases
Prostate cancer
24 genes, 58 drugs (DrugBank) and 92 diseases
Proteoglycans in cancer
34 genes, 75 drugs (DrugBank) and 107 diseases
Purine metabolism
30 genes, 44 drugs (DrugBank) and 82 diseases
Rap1 signaling pathway
47 genes, 115 drugs (DrugBank) and 101 diseases
Ras signaling pathway
38 genes, 65 drugs (DrugBank) and 77 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Renin secretion
28 genes, 90 drugs (DrugBank) and 108 diseases
Signaling pathways regulating pluripotency of stem cells
21 genes, 39 drugs (DrugBank) and 64 diseases
Sphingolipid signaling pathway
32 genes, 56 drugs (DrugBank) and 84 diseases
Taste transduction
29 genes, 93 drugs (DrugBank) and 78 diseases
Terpenoid backbone biosynthesis
4 genes, 14 drugs (DrugBank) and 62 diseases
Th1 and Th2 cell differentiation
45 genes, 57 drugs (DrugBank) and 83 diseases
Th17 cell differentiation
57 genes, 88 drugs (DrugBank) and 111 diseases
Thermogenesis
17 genes, 31 drugs (DrugBank) and 89 diseases
Thyroid cancer
8 genes, 18 drugs (DrugBank) and 35 diseases
Tight junction
13 genes, 38 drugs (DrugBank) and 54 diseases
Toll-like receptor signaling pathway
41 genes, 68 drugs (DrugBank) and 84 diseases
Toxoplasmosis
41 genes, 53 drugs (DrugBank) and 78 diseases
Transcriptional misregulation in cancer
28 genes, 64 drugs (DrugBank) and 83 diseases
Tuberculosis
67 genes, 80 drugs (DrugBank) and 104 diseases
Vascular smooth muscle contraction
32 genes, 95 drugs (DrugBank) and 74 diseases
Viral carcinogenesis
32 genes, 34 drugs (DrugBank) and 60 diseases
